Key result
Higher serum carotenoids linked to ~50% fewer severe COPD exacerbations per SD in low-income individuals.
Why the study?
Diet-derived carotenoids may counteract inflammation and improve outcomes in COPD, a chronic inflammatory disease, but their specific associations needed evaluation.
Are higher serum carotenoid levels associated with improved COPD outcomes and reduced inflammation in low-income individuals with COPD?
Population
98 low-income individuals with COPD in the Baltimore, Maryland area
Comparison
Higher vs lower serum carotenoid levels
Design
Longitudinal cohort study
Authors
Loading...
Hypothesis-generating for carotenoids in low-income COPD; does not support practice change without trials.
Cohort (n=98)
No
Are higher serum carotenoid levels associated with improved COPD outcomes and reduced inflammation in low-income individuals with COPD?
Relative Risk: 0.5 (95% CI 0.3–0.8)
Higher serum carotenoid levels are associated with better health status, fewer severe exacerbations, and lower systemic inflammation in low-income patients with COPD.
Jackson et al. (2026) conducted a cohort in COPD (n=98). Serum carotenoid levels vs. Lower serum carotenoid levels was evaluated on Severe exacerbation frequency (IRR 0.50, 95% CI 0.3-0.8). Each 1 standard deviation increase in total serum carotenoid levels was associated with a 50% lower incidence of severe exacerbations (IRR 0.50) in low-income individuals with COPD.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: